Additionally, bone marrow-derived hematopoietic stem cells expressing type 2 C-C chemokine receptor (CCR2+ HSCs) preferentially migrate to tumor tissues and differentiate into APCs in the tumor microenvironment. The gene discussed is CCR2; the disease is neoplasm.